O
CMPS

OrbiMed’s Compass Pathways CMPS Stock Holding History

OrbiMed’s Portfolio CMPS Stock Details CMPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,150,646
Closed -$6.36M – 137
2026
Q1 		$6.36M Buy
+1,150,646
New +$7.74M 0.13% 88
2021
Q2 		– Sell
-127,816
Closed -$4.71M – 163
2021
Q1 		$4.71M Sell
127,816
-222,184
-63% -$9.74M 0.04% 146
2020
Q4 		$16.7M Hold
350,000
– – 0.15% 109
2020
Q3 		$12.2M Buy
+350,000
New +$12.6M 0.15% 103

Other funds holding CMPS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

OrbiMed's CMPS Position: Q2 2026 in Review

OrbiMed sold out of Compass Pathways (CMPS) in Q2 2026, closing a stake of 1,150,646 shares — an estimated $6.36M sold.

OrbiMed first reported a position in CMPS in Q3 2020 and held it in 4 quarters. The position peaked at $16.7M in Q4 2020. 223 funds tracked by Wall St. Rank hold CMPS as of Q2 2026.

  • OrbiMed reported no remaining Compass Pathways position as of Q2 2026 after selling out during the quarter.
  • OrbiMed sold 1,150,646 Compass Pathways shares in Q2 2026, an estimated $6.36M.
  • OrbiMed first reported a position in Compass Pathways in Q3 2020 and held it in 4 quarters.
  • OrbiMed's Compass Pathways position peaked at $16.7M in Q4 2020.
  • 223 funds tracked by Wall St. Rank held Compass Pathways as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.